EichorEICHOR
Study identifier: NCT07598669 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: RecruitingPBC-AUT

Austrian PBC Registry

Condition: Primary Biliary Cholangitis · Liver Cirrhosis · Portal Hypertension  ·  Sponsor: Medical University of Vienna

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNoCheck eligibility criteria ↓
Where11 locations

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The goal of this registry is to better understand how primary biliary cholangitis develops over time, including the role of disease-related biomarkers, complications of the disease, and symptom burden. Patients with primary biliary cholangitis treated at participating centres in Austria will be invited to take part in this prospective registry. Participation in an associated biobank is optional. Clinical and laboratory data will be collected, and patients will be followed regularly through scheduled clinic visits. In addition, biological samples (serum, plasma, and, if available, liver tissue) may be collected and stored in the biobank for future research.

This description comes directly from the study's public registry record.

Talk to the study team

Michael Trauner, MD  ·  +43 1 40400 47410  ·  Michael.Trauner@meduniwien.ac.at

Benedikt S Hofer, MD  ·  +43 1 40400 47410  ·  Benedikt.S.Hofer@meduniwien.ac.at

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Age \>18 years * Confirmed diagnosis of primary biliary cholangitis (at least two of the following three criteria must be fulfilled: persistent elevation of alkaline phosphatase above the upper limit of normal for at least 6 months; presence of antimitochondrial antibodies or PBC-specific antinuclear antibodies; characteristic histopathology) * Written informed consent for participation in the registry Exclusion Criteria: * Withdrawal of written informed consent

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (11)

Klinikum Klagenfurt am WörtherseeKlagenfurt, Carinthia, AustriaNot Yet Recruiting
Universitätsklinikum St. PöltenSankt Pölten, Lower Austria, AustriaNot Yet Recruiting
Universitätsklinikum SalzburgSalzburg, State of Salzburg, AustriaNot Yet Recruiting
Klinik LandstraßeVienna, State of Vienna, AustriaNot Yet Recruiting
Medizinische Universität WienVienna, State of Vienna, AustriaRecruiting
Klinik OttakringVienna, State of Vienna, AustriaNot Yet Recruiting
Medizinische Universität GrazGraz, Styria, AustriaNot Yet Recruiting
Medizinische Universität InnsbruckInnsbruck, Tyrol, AustriaNot Yet Recruiting
Ordensklinikum Linz - Barmherzige SchwesternLinz, Upper Austria, AustriaNot Yet Recruiting
Kepler UniversitätsklinikumLinz, Upper Austria, AustriaNot Yet Recruiting
Klinikum Wels-GrieskirchenWels, Upper Austria, AustriaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →